<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>One hundred and twenty-eight cases of high-grade malignant B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> were studied with a plastic re-embedding technique and classified according to the Kiel classification </plain></SENT>
<SENT sid="1" pm="."><plain>The cytological details could be better recognized than in the original paraffin sections, thus permitting a more precise definition of the various <z:hpo ids='HP_0002665'>lymphoma</z:hpo> types </plain></SENT>
<SENT sid="2" pm="."><plain>The entities <z:e sem="disease" ids="C1516391" disease_type="Neoplastic Process" abbrv="">centroblastic</z:e> and <z:e sem="disease" ids="C1521815" disease_type="Neoplastic Process" abbrv="">immunoblastic</z:e> <z:hpo ids='HP_0002665'>lymphoma</z:hpo> are more precisely defined and supplemented by the addition of several new variants </plain></SENT>
<SENT sid="3" pm="."><plain>In contrast to the present Kiel classification we separate Burkitt's from lymphoblastic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>In <z:hpo ids='HP_0000001'>all</z:hpo> cases investigated, the B-cell nature of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> cells was proven by immunohistochemistry using monoclonal antibodies </plain></SENT>
<SENT sid="5" pm="."><plain>The four entities of high-grade malignant B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> described in this paper are: (1) <z:e sem="disease" ids="C1516391" disease_type="Neoplastic Process" abbrv="">centroblastic</z:e> <z:hpo ids='HP_0002665'>lymphoma</z:hpo> with four morphological variants (monomorphic, polymorphic, multilobated and centrocytoid); (2) <z:e sem="disease" ids="C1521815" disease_type="Neoplastic Process" abbrv="">immunoblastic</z:e> <z:hpo ids='HP_0002665'>lymphoma</z:hpo> with three morphological variants (with or without plasmacytic differentiation, with many lymphocytes); (3) Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and the closely related Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>-like <z:hpo ids='HP_0002665'>lymphoma</z:hpo> with plasmablastic differentiation; and (4) lymphoblastic <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="6" pm="."><plain>Only the <z:e sem="disease" ids="C1516391" disease_type="Neoplastic Process" abbrv="">centroblastic</z:e> <z:hpo ids='HP_0002665'>lymphomas</z:hpo> (in 17%) showed occasional follicular growth pattern, which further confirms the view that they are derived from germinal centre cells </plain></SENT>
</text></document>